Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors

Neuroendocrinology

Volumn 86, Issue 2, 2007, Pages 112-118

  Lindberg, Daniel ^a   Hessman, Ola ^a   Åkerström, Göran ^a   Westin, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

c Myc; CDK4 mRNA; Pancreatic endocrine tumors; Quantitative PCR; Western blot

Indexed keywords

CYCLIN DEPENDENT KINASE 4; MESSENGER RNA; MYC PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENDOCRINE TUMOR; ENZYME ANALYSIS; ENZYME ASSAY; EXON; GENE AMPLIFICATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE C MYC; PANCREAS ISLET BETA CELL; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ANALYSIS; WESTERN BLOTTING;

CYCLIN-DEPENDENT KINASE 4; GENE EXPRESSION REGULATION, NEOPLASTIC; HIPPEL-LINDAU DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34848848753     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106762     Document Type: Article

References (39)

1. Åkerström G, Hellman P, Hessman O, Osmak L: Surgical treatment of endocrine pancreatic tumours. Neuroendocrinology 2004;80:62-66.
2. Åkerström G, Hessman O, Hellman P, Skogseid B: Pancreatic tumours as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol 2005;19:819-830.
3. Öberg K, Eriksson B: Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005;19:753-781.
4. House MG, Schulick RD: Endocrine tumors of the pancreas. Curr Opin Oncol 2006;18:23-29.
5. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM: The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005;104:2292-2309.
6. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Speigel AM, Burns AL, Mark SJ: Positional cloning of the gene for multiple neoplasia type 1. Science 1997;276:404-407.
7. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns AL, Collins FS, Spiegel AM, Marx SJ: Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metabol Res 2005;37:369-374.
8. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M, Guru SC, Manickam P, Olufemi SE, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Lubensky A: Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 1997;57:4682-4686.
9. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Akerstrom G, Westin G: Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 1998;58:377-379.
10. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr, Sawicki MP: Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res 1998;58:4417-4420.
11. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A: A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 1997;100:404-410.
12. Hessman O, Lindberg D, Einarsson A, Lillhager P, Carling T, Grimelius L, Eriksson B, Akerstrom G, Westin G, Skogseid B: Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN1-associated pancreatic endocrine tumors. Genes Chromosomes Cancer 1999;26:258-264.
13. Barghorn A, Komminoth P, Bachmann D, Rutimann K, Saremaslani P, Muletta-Feurer S, Perren A, Roth J, Heitz PU, Speel EJ: Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J Pathol 2001;194:451-458.
14. Costa-Guda J, Rosen ED, Jensen RT, Chung DC, Arnold A: Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours. Clin Endocrinol 2005;62:603-606.
15. Lindberg D, Åkerström G, Westin G: Mutational analyses of WNT7A and HDAC11 as candidate tumor suppressor genes in sporadic malignant pancreatic endocrine tumors. Clin Endocrinol 2007;66:110-114.
16. Ortega S, Malumbres M, Barbacid M: Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87.
17. Kim WY, Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell 2006;127:265-275.
18. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation result in β-islet cell hyperplasia. Nat Genet 1999;22:44-52.
19. Sotillo R, Dubus P, Martin J, de la Cueva E, Ortega S, Malumbres M, Barbacid M: Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J 2001;20:6637-6647.
20. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC: Overexpression of cyclin D1 in pancreatic β cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 2005;54:712-719.
21. Cozar-Castellano I, Takane KK, Bottino R, Balamurugan AN, Stewart AF: Induction of β-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes 2004;53:149-159.
22. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M, Kim SK: Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 2005;102:14659-14664.
23. Ratineau C, Bernard C, Poncet G, Blanc M, Josso C, Fontaniere S, Calender A, Chayvialle JA, Zhang CX, Roche C: Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. J Biol Chem 2004;279:24477-24484.
24. Chung DC, Brown SB, Graeme-Cook F, Seto M, Warshaw AL, Jensen RT, Arnold A: Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metabol 2000;85:4373-4378.
25. Guo SS, Wu X, Shimoide AT, Wong J, Moatamed F, Sawicki MP: Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours. J Endocrinol 2003;179:73-79.
26. Deroanne CF, Bonjean K, Servotte S, Devy L, Colige A, Clausse N, Blacher S, Verdin E, Foidart JM, Nusgens BV, Castronovo V: Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 2002;21:427-436.
27. 3-1α-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metabol 2002;87:2967-2972.
28. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW: Identification of CDK4 as a target of c-Myc. Proc Natl Acad Sci USA 2000;97:2229-2234.
29. Pavelic K, Hrascan R, Kapitanovic S, Karapandza N, Vranes Z, Belicza M, Kruslin B, Cabrijan T: Multiple genetic alterations in malignant metastatic insulinomas. J Pathol 1995;177:395-400.
30. Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ, Stambrook P, Gluckman JL, Pavelic ZP: Molecular genetics of malignant insulinoma. Anticancer Res 1996;16:1707-1718.
31. Wang DG, Johnston CF, Buchanan KD: Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Cancer 1997;80:668-675.
32. Pelengaris S, Khan M, Evan GI: Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002;109:321-334.
33. Wang H, Goode T, Iakova P, Albrecht JH, Timchenko NA: C/EBPα- triggers proteasome-dependent degradation of Cdk4 during growth arrest. EMBO J 2002;21:930-941.
34. Muscarella P, Melvin WS, Fisher WE, Foor J, Ellison EC, Herman JG, Schirmer WJ, Hitchcock CL, DeYoung BR, Weghorst CM: Genetic alterations in gastrinomas and non-functioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res 1998;58:237-240.
35. Bartsch DK, Kersting M, Wild A, Ramaswamy A, Gerdes B, Schuermann M, Simon B, Rothmund M: Low frequency of p16(INK4a) alterations in insulinomas. Digestion 2000;62:171-177.
36. Serrano J, Goebel SU, Peghini PL, Lubensky IA, Gibril F, Jensen RT: Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas. J Clin Endocrinol Metabol 2000;85:4146-4156.
37. Lee YM, Sicinski P: Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human. Cell Cycle 2006;5:2110-2114.
38. Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E, Albassam M, Zheng X, Leopold WR, Pryer NK, Toogood PL: Specific inhibition of cyclin dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 2004;3:1427-1437.
39. Baughn LB, Di Liberto M, Wu K, Toogood PL, Louie T, Gottschalk R, Niesvizky R, Cho H, Ely S, Moore MA, Chen-Kiang S: A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Cancer Res 2006;66:7661-7667.